Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



SPMS Patients Have Higher Illness Burden than RRMS Patients, Kantar Health Study Shows

Patients with secondary progressive MS (SPMS) have a higher burden of illness than patients with relapsing-remitting MS, a new study showed.

The study, “Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey,” appeared  in the journal Neuropsychiatric Disease and Treatment.

Most MS patients experience RRMS, a form of the disease characterized by relapses and remission of symptoms. A subset of MS patients have another form of the disease — primary progressive MS (PPMS), which is when the illness progresses continuously without any remission. Patients who initially have RRMS followed by a progressive phase are diagnosed with SPMS.

The progression from RRMS to SPMS is fairly common in the absence of treatment. In fact, SPMS occurs in half of all RRMS patients within 10 years, and in up to 90 percent of patients within 25 years. While drugs may help stall the process, no one has studied this in depth.

Patients with SPMS have a poorer prognosis, since SPMS is associated with severe and irreversible disability. Even so, more studies have investigated RRMS than SPMS, limiting knowledge about the burden of illness and demographic data regarding SPMS patients.

Furthermore, while therapeutic options for RRMS patients have increased over the years, they have not for SPMS patients — leading researchers at New York-based Kantar Health to undertake a study to determine the characteristics of people with SPMS and their burden of illness relative to RRMS.

They used patient responses from the 2012 and 2013 U.S. National Health and Wellness Survey to determine differences in severity of disease, symptoms, healthcare resources, use of disease-modifying drugs and demographics between SPMS and RRMS patients. They also analyzed a 36-question form about work productivity and activity impairment.

SPMS patients were older (55.7 years old on average) than RRMS patients (48.9 years), results showed. Furthermore, a higher ratio of SPMS patients were likely to be males (43.8 percent) than RRMS patients (28.4 percent). In addition, 20 percent of SPMS patients were employed, versus 39.7 percent of RRMS patients.

SPMS patients also described their disease as more severe, and reported neurological symptoms more frequently. They also had higher hospitalization rates than RRMS patients, used disease-modifying drugs less frequently, and suffered higher activity impairment than their counterparts with RRMS. Physical functioning in general was lower in SPMS patients than in RRMS patients.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length
Click here to read more

Labels: ,

Go to Newer News Go to Older News